• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

8,110
4,313
4,195
3,553
3,481

COUNTRY

3,019
990
306
289
268

CATEGORIES

  • 958
  • 181
    • 44
    • 266
    • 45
  • 202
  • 826
    • 55
  • 510
  • 702
  • 242
  • 61
  • 67
  • 882
  • 1,547
  • 78
  • 20
  • 510
  • 1,461
  • 2,432
    • 85
    • 124
    • 66
    • 65
    • 37
    • 37
    • 12
    • 12
    • 11
    • 18
  • 23
  • 273
  • 37
  • 2,726
  • 920
  • 209
SHOW ALL…

PRICE

5,216
9,860
21,967
30,576

PUBLISHED

160
3,899
11,972
30,576

PRODUCT TYPE

27,736
1,270
1,172
169
73
58
43
21
16
10
6
1
1

Pharmaceuticals

(30,576 Products)

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

Type 2 Diabetes - Pipeline Review, H1 2015

Type 2 Diabetes - Pipeline Review, H1 2015 Summary This, ‘Type 2 Diabetes - Pipeline Review, H1 2015’, provides an overview of the Type 2 Diabetes’s therapeutic pipeline. This report provides comprehensive...

February 2015
FROM

Leukodystrophies - Pipeline Review, H1 2015

Leukodystrophies - Pipeline Review, H1 2015 Summary This, ‘Leukodystrophies - Pipeline Review, H1 2015’, provides an overview of the Leukodystrophies’s therapeutic pipeline. This report provides...

February 2015
FROM

Obesity - Pipeline Review, H1 2015

Obesity - Pipeline Review, H1 2015 Summary This, ‘Obesity - Pipeline Review, H1 2015’, provides an overview of the Obesity’s therapeutic pipeline. This report provides comprehensive information on...

February 2015
FROM

Exocrine Pancreatic Insufficiency - Pipeline Review, H1 2015

Exocrine Pancreatic Insufficiency - Pipeline Review, H1 2015 Summary This, ‘Exocrine Pancreatic Insufficiency - Pipeline Review, H1 2015’, provides an overview of the Exocrine Pancreatic Insufficiency’s...

February 2015
FROM

Anal Cancer - Pipeline Review, H1 2015

Anal Cancer - Pipeline Review, H1 2015 Summary This, ‘Anal Cancer - Pipeline Review, H1 2015’, provides an overview of the Anal Cancer’s therapeutic pipeline. This report provides comprehensive information...

February 2015
FROM

Acute Lymphoblastic Lymphoma - Pipeline Review, H1 2015

Acute Lymphoblastic Lymphoma - Pipeline Review, H1 2015 Summary This, ‘Acute Lymphoblastic Lymphoma - Pipeline Review, H1 2015’, provides an overview of the Acute Lymphoblastic Lymphoma’s therapeutic...

February 2015
FROM

Hypogonadotropic Hypogonadism - Pipeline Review, H1 2015

Hypogonadotropic Hypogonadism - Pipeline Review, H1 2015 Summary This, ‘Hypogonadotropic Hypogonadism - Pipeline Review, H1 2015’, provides an overview of the Hypogonadotropic Hypogonadism’s therapeutic...

February 2015
FROM

Oropharyngeal Candidiasis - Pipeline Review, H1 2015

Oropharyngeal Candidiasis - Pipeline Review, H1 2015 Summary This, ‘Oropharyngeal Candidiasis - Pipeline Review, H1 2015’, provides an overview of the Oropharyngeal Candidiasis’s therapeutic pipeline. This...

February 2015
FROM

Polycythemia Vera - Pipeline Review, H1 2015

Polycythemia Vera - Pipeline Review, H1 2015 Summary This, ‘Polycythemia Vera - Pipeline Review, H1 2015’, provides an overview of the Polycythemia Vera’s therapeutic pipeline. This report provides...

February 2015
FROM

Spinal Stenosis - Pipeline Review, H1 2015

Spinal Stenosis - Pipeline Review, H1 2015 Summary This, ‘Spinal Stenosis - Pipeline Review, H1 2015’, provides an overview of the Spinal Stenosis’s therapeutic pipeline. This report provides comprehensive...

February 2015
FROM

Anxiety Disorders - Pipeline Review, H1 2015

Anxiety Disorders - Pipeline Review, H1 2015 Summary This, ‘Anxiety Disorders - Pipeline Review, H1 2015’, provides an overview of the Anxiety Disorders’s therapeutic pipeline. This report provides...

February 2015
FROM

Muscle Atrophy - Pipeline Review, H1 2015

Muscle Atrophy - Pipeline Review, H1 2015 Summary This, ‘Muscle Atrophy - Pipeline Review, H1 2015’, provides an overview of the Muscle Atrophy’s therapeutic pipeline. This report provides comprehensive...

February 2015
FROM

Vulvovaginal Candidiasis - Pipeline Review, H1 2015

Vulvovaginal Candidiasis - Pipeline Review, H1 2015 Summary This, ‘Vulvovaginal Candidiasis - Pipeline Review, H1 2015’, provides an overview of the Vulvovaginal Candidiasis’s therapeutic pipeline. This...

February 2015
FROM

Gastroparesis - Pipeline Review, H1 2015

Gastroparesis - Pipeline Review, H1 2015 Summary This, ‘Gastroparesis - Pipeline Review, H1 2015’, provides an overview of the Gastroparesis’s therapeutic pipeline. This report provides comprehensive...

February 2015
FROM

Trigeminal Neuralgia - Pipeline Review, H1 2015

Trigeminal Neuralgia - Pipeline Review, H1 2015 Summary This, ‘Trigeminal Neuralgia - Pipeline Review, H1 2015’, provides an overview of the Trigeminal Neuralgia’s therapeutic pipeline. This report...

February 2015
FROM

Leber's Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) - Pipeline Review, H1 2015

Leber’s Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) - Pipeline Review, H1 2015 Summary This, ‘Leber’s Hereditary Optic Neuropathy (LHON) (Leber optic atrophy) - Pipeline Review, H1 2015’,...

February 2015
FROM

Edema - Pipeline Review, H1 2015

Edema - Pipeline Review, H1 2015 Summary This, ‘Edema - Pipeline Review, H1 2015’, provides an overview of the Edema’s therapeutic pipeline. This report provides comprehensive information on the...

February 2015
FROM

Viral Conjunctivitis - Pipeline Review, H1 2015

Viral Conjunctivitis - Pipeline Review, H1 2015 Summary This, ‘Viral Conjunctivitis - Pipeline Review, H1 2015’, provides an overview of the Viral Conjunctivitis’s therapeutic pipeline. This report...

February 2015
FROM

Lipodystrophy - Pipeline Review, H1 2015

Lipodystrophy - Pipeline Review, H1 2015 Summary This, ‘Lipodystrophy - Pipeline Review, H1 2015’, provides an overview of the Lipodystrophy’s therapeutic pipeline. This report provides comprehensive...

February 2015
FROM

Acquired (Autoimmune) Hemolytic Anemia - Pipeline Review, H1 2015

Acquired (Autoimmune) Hemolytic Anemia - Pipeline Review, H1 2015 Summary This, ‘Acquired (Autoimmune) Hemolytic Anemia - Pipeline Review, H1 2015’, provides an overview of the Acquired (Autoimmune)...

February 2015
FROM
Loading Indicator

Our Clients

Pfizer, Inc. Grünenthal GmbH GlaxoSmithKline PLC Abbott Laboratories Ltd. Roche Diagnostics Ltd. Novo Nordisk A/S